Latest resources and news surrounding Novartis data featured at the 62nd American Society of Hematology Annual Meeting (ASH).
How changes driven by COVID-19 may shape pharma manufacturing in the long term.
What are the key factors ensuring Novartis supply chains remain operational during the pandemic?
Annual meeting highlights progress on the company’s transformation and growth strategy.
Novartis researchers aim to preserve kidney function – and quality of life – for patients.
Novartis researchers are using data to accelerate drug development.
Five virtual power purchase agreements with three developers expected to add more than 275 megawatts of clean power to the electrical grid.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.